Preoperative transfusion versus no transfusion policy in sickle cell disease patients: a randomized trial.

Mohamed ElshinawyNada Al MarhoobiRashid Al AbriHanan F NazirDoaa KhaterManar MaktoomAbdulhakim Al-RawasSurekha T MevadaIslam ElghamryYasser Wali

Published in: Transfusion (2021)

Sickle cell disease patients with a hemoglobin level above 7.5 g/dL do not need PRBCs transfusion prior to adenotonsillectomy. This approach did not increase the risk of postoperative surgical or SCD-related complications.

Keyphrases

sickle cell disease
end stage renal disease
patients undergoing
ejection fraction
newly diagnosed
healthcare
obstructive sleep apnea
public health
peritoneal dialysis
prognostic factors
mental health
risk factors